Pharmaceuticals
Our global Pharmaceuticals portfolio includes more than 45 key marketed products, many of which are leaders in their respective therapeutic areas. We have received 17 new pharmaceutical product approvals in the US since 2000, the most of any pharmaceutical company.
Key pharmaceutical products marketed by Novartis are listed below by therapeutic area.
Click on the product link where available to display complete product information. Please note that some product links are intended for US residents only.
View by therapeutic area
Diovan HCT/Co-Diovan (valsartan and hydrochlorothiazide)
Hypertension
Visit www.diovan.com (US residents only)
Diovan (valsartan)
Hypertension
Visit www.diovan.com (US residents only)
Exforge (valsartan and amlodipine besylate)
Hypertension
Visit www.exforge.com (US residents only)
Rasilez/Tekturna (aliskiren)
Hypertension
Visit www.tekturna.com (US residents only)
Aclasta/Reclast (zoledronic acid 5 mg solution for infusion)
Postmenopausal osteoporosis and Paget's disease of the bone
Cubicin (daptomycin)
Skin and soft-tissue infections
Visit www.cubicin.com (US residents only)
Tyzeka/Sebivo (telbivudine)
Chronic hepatitis B
Visit www.tyzeka.com (US residents only)
Myfortic (mycophenolic acid)
Used to prevent organ rejection in patients with kidney transplants
Visit www.myfortic.com (US residents only)
Neoral (cyclosporine)
Used to prevent organ rejection following a kidney, liver or heart transplant
Exelon/Exelon Patch (rivastigmine tartrate)
Alzheimer's disease and mild to moderate dementia associated with Parkinson's disease
Visit www.exelon.com (US residents only)
Ritalin LA (methylphenidate hydrochloride)
Attention-deficit hyperactivity disorder (ADHD) in children and adults
Visit www.ADHDinfo.com (US residents only)
Focalin XR (dexmethylphenidate HCl)
Attention-deficit hyperactivity disorder (ADHD) in adults, adolescents and children
Visit www.focalinxr.com (US residents only)
Stalevo (carbidopa/levodopa/entacapone)
Parkinson's disease
Visit www.stalevo.com (US residents only)
Trileptal (oxcarbazepine)
Epilepsy
Visit www.trileptal.com (US residents only)
Lucentis (ranibizumab)
Wet form of age-related macular degeneration (AMD), a leading cause of blindness
Exjade (deferasirox)
Chronic iron overload in transfusion-related conditions
Visit www.exjade.com
Femara (letrozole)
Breast cancer in post-menopausal women
Visit www.femarainfo.com
Visit www.femara.com (US residents only)
Gleevec/Glivec (imatinib mesylate/imatinib)
Certain forms of leukemia, gastrointestinal stromal (GIST) tumors and various rare cancers
Visit www.glivec.com
Visit www.gleevec.com (US residents only)
Sandostatin SC/Sandostatin LAR (octreotide acetate)
Acromegaly, carcinoid tumors and other types of gastrointestinal neuroendocrine and pancreatic tumors
Visit www.sandostatin.com
Visit www.us.sandostatin.com (US residents only)
Tasigna (nilotinib)
Certain forms of leukemia no longer responding to other therapies
Visit www.tasigna.com
Zometa (zoledronic acid)
Cancers that have spread (or "metastasized") to the bones from solid tumors
Visit www.zometa.com
Visit www.us.zometa.com (US residents only)
Xolair (omalizumab)
Biotechnology therapy for allergic asthma
Visit www.xolair.com (US residents only)
Pharmaceuticals business at Novartis
Novartis discovers and develops innovative medicines with improved efficacy and fewer side-effects.
Current alliances
Our collaborative efforts differentiate us from other healthcare companies.
Magic Cancer Bullet
In this book, Dr. Vasella recounts the story of our revolutionary cancer drug Glivec/Gleevec.
Focus on patients
We are dedicated to creating value for patients.